Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 189028-93-1 | Product Number: P2111
(S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-2-oxazolidinone
×
![]()
×
![(S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-2-oxazolidinone](/_ui/responsive/theme-tci/images/missing_product_zoom.jpg "(S)-4-Phenyl-3-[5-(4-fluorophenyl)-5-oxopentanoyl]-2-oxazolidinone")
Purity: >98.0%(HPLC)(N)
Synonyms:
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 5G |
€60.00
|
1 | 17 |
|
| 25G |
€250.00
|
1 | 21 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | P2111 |
| Purity / Analysis Method | >98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__2__0H__1__8FNO__4 = 355.37 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 189028-93-1 |
| Reaxys Registry Number | 9077797 |
| PubChem Substance ID | 253660310 |
| MDL Number | MFCD08061377 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 90.0 to 94.0 °C |
| Specific rotation [a]20/D | +49.0 to +54.0 deg(C=0.2, CHCL3) |
Properties (reference)
| Melting Point | 92 °C |
| Specific Rotation | 52° (C=0.2,CHCl3) |
| Solubility (soluble in) | Acetone |
GHS
Related Laws:
Transport Information:
| HS Number | 2934999090 |
Application
An Intermediate in the Synthesis of Ezetimibe
This reagent is an intermediate in the synthesis of ezetimibe, which is a selective acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor used in hypercholesterolemia.
References
- Process for preparing Ezetimibe intermediate by an acid enhanced chemo- and enantioselective CBS catalyzed ketone reduction
- Process for preparing Ezetimibe intermediate by enantioselective CBS catalyzed ketone reduction with BH3-DEA prepared in situ
- Burkholderia cenocepacia: a new biocatalyst for efficient bioreduction of ezetimibe intermediate
- Lipase catalyzed kinetic resolution for the production of (S)-3-[5-(4-fluoro-phenyl)-5-hydroxy-pentanoyl]-4-phenyloxazolidin-2-one: An intermediate for the synthesis of ezetimibe
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.